The store will not work correctly when cookies are disabled.
3-(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-7-yl)-N-(4-chlorophenyl)propanamide
ID: ALA4537197
PubChem CID: 155548307
Max Phase: Preclinical
Molecular Formula: C16H15BClNO3
Molecular Weight: 315.56
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CCc1cccc2c1B(O)OC2)Nc1ccc(Cl)cc1
Standard InChI: InChI=1S/C16H15BClNO3/c18-13-5-7-14(8-6-13)19-15(20)9-4-11-2-1-3-12-10-22-17(21)16(11)12/h1-3,5-8,21H,4,9-10H2,(H,19,20)
Standard InChI Key: HABSLBVZXGPVJT-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
23.8457 -10.0085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8446 -10.8280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5526 -11.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5508 -9.5996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2594 -10.0049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2642 -10.8235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0443 -11.0720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5216 -10.4068 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.0365 -9.7474 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0
26.2845 -8.9688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5484 -8.7824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8395 -8.3760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8370 -7.5588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1281 -7.1523 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.5435 -7.1481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.4216 -7.5630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7160 -7.1524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0100 -7.5624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0120 -8.3805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7259 -8.7868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4290 -8.3744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3061 -8.7921 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 1 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 315.56 | Molecular Weight (Monoisotopic): 315.0834 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Zhang J, Zhang J, Hao G, Xin W, Yang F, Zhu M, Zhou H.. (2019) Design, Synthesis, and Structure-Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents., 62 (14): [PMID:31264855] [10.1021/acs.jmedchem.9b00736] |